Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries
By JoanneRUSSELL25
(PRWEB) July 22, 2013
The Institute of Regenerative and Molecular Orthopaedics (IRMO), world-renowned stem cell therapy experts, applauds the use of stem cell therapy for treatment of spinal injuries. In recent times, stem cell therapy has been increasingly sought after to support treatments of various injuries, especially in the sports world. Its use in repairing spinal injuries comes as good news to the thousands of Americans currently living with spinal cord injuries who are seeking the latest in breakthrough medical solutions.
Stem cell therapy is of the most exciting and promising treatments in modern medicine. Inroads are made every day, as the many applications of stem cell treatments become better understood by medical professionals around the world. Experts, like Dr. Joseph Purita of the Institute of Regenerative and Molecular Orthopaedics, have been utilizing stem cell treatments for many years to treat sports injuries.
Recent scientific and technological advancements have made stem cell extraction relatively inexpensive and accessible. Today, medical professionals have unprecedented access to these remarkable cells and are increasingly applying them in new ways to better aid in the bodys repair process. This includes advances in platelet rich plasma therapy (PRP), a process that takes a concentration of a persons own plasma and injects it into areas in need of new growth and tissue repair.
The use of stem cell therapy in the treatment of spinal cord injuries presents probably the biggest challenge yet for proponents of the treatment. Researchers are increasingly using stem cells to hopefully better understand its capabilities. The hope for spinal cord injuries is that one day stem cells can be used to generate new passageways for nerve signals to connect to muscles. The more stem cells are used for treatment in spinal cord injuries, the closer the medical field will be to fulfilling this promise.
Headed by the world-renowned stem cell treatment pioneer, Dr. Purita, the Institute of Regenerative and Molecular Orthopaedics is continually advancing the world of stem cell therapy treatments. They are one of the few orthopedic practices in existence that utilizes stem cell therapy, and PRP therapy, with orthopedic surgery to maximize a patients recovery outcome. As more stem cell treatments are being used to treat spinal injuries, Dr. Purita and his group look forward to seeing what great strides are made in battling the crippling condition in the near future.
About Stem Cell Orthopedic: The Institute of Regenerative and Molecular Orthopaedics (IRMO) is a world-class orthopedic practice and stem cell facility staffed with seasoned board certified orthopedic surgeons. They differ from most orthopedic practices because they offer stem cells and platelet rich plasma (PRP) therapy in conjunction with surgery or as alternative to surgical procedures. They utilize state-of-the-art technology and the latest in stem cell research to best treat their patients. IRMO uses hematopoietic stem cells (HSC), which are found circulating in blood, fat, and bone marrow, to help repair the body. They are headed by Medical Director, Dr. Joseph Purita, a world-renowned pioneer in laser orthopedic surgery and graduate of the esteemed Georgetown University Medical School. For more information, visit http://www.stemcellorthopedic.com/ or follow them on Facebook, Twitter, or YouTube.
See the original post:
Stem Cell Orthopedic Applauds Use of Stem Cell Therapy for Spinal Injuries
De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)
By raymumme
LAST week, we discussed the potential of medical tourism in the country which will also provide opportunities for destinations like Baguio once tapped, and subject to competitive and international standards and government/ regulatory requirements.
So much has been written and reported about Stem Cell Therapy including its extraordinary promises that research holds for the treatment of a wide range of diseases and conditions.
This week, lets delve deeper.
What is Stem Cell Therapy?
Cell Therapy has been interchangeably called many names such as cellular therapy, fresh cell therapy, live cell therapy, glandular therapy, or xenograph or xenotransplant therapy.
The International Society for Stem Cell Research (ISSCR) describes stem cell therapy as a treatment that uses stem cells, or cells that come from stem cells, to replace or to repair a patients cells or tissues that are damaged. The stem cells might be put into the blood, or transplanted into the damaged tissue directly, or even recruited from the patients own tissues for self-repair.
Stem Cells have been differentiated based on where in the body or what stage in development they come from. ISCCR has enumerated them as follows (source:www.isscr.org):
1. Adult Stem Cells or Tissue-specific Stem Cells. Many adult tissues contain stem cells that can replace cells that die or restore tissue after injury. Skin, muscle, intestine and bone marrow, for example, each contain their own stem cells. In the bone marrow, billions of new blood cells are made every day from blood-forming stem cells. Adult stem cells are tissue-specific, meaning they are found in a given tissue in our bodies and generate the mature cell types within that particular tissue or organ. It is not clear whether all organs, such as the heart, contain stem cells. The term adult stem cells is often used very broadly and may include fetal and cord blood stem cells.
Another type of adult stem cell is the mesenchymal stem cell. These are found in a number of tissues, including bone marrow, and may be able to produce bone, cartilage and fat. It is also possible that these or similar cells may aid in the regeneration of tissues. Extensive animal studies are currently ongoing to determine if these cells may be used for treatment of diseases such as arthritis and non-healing bone fractures. It is also possible that these or similar cells modulate the immune system in response to injury.
2. Fetal Stem Cells. Fetal stem cells are taken from the fetus. The developing baby is referred to as a fetus from approximately 10 weeks of gestation. Most tissues in a fetus contain stem cells that drive the rapid growth and development of the organs. Like adult stem cells, fetal stem cells are generally tissue-specific, and generate the mature cell types within the particular tissue or organ in which they are found.
Go here to see the original:
De Leon: Medical Tourism and the Future of Stem Cell Therapy (Part 2)
‘The results are profound’; Stem cell therapy used to treat animal ailments – Video
By Sykes24Tracey
#39;The results are profound #39;; Stem cell therapy used to treat animal ailments
#39;The results are profound #39;; Stem cell therapy used to treat animal ailments.
By: kgun9
Read more:
'The results are profound'; Stem cell therapy used to treat animal ailments - Video
FAQ1-Stem Cell Therapy – Video
By Sykes24Tracey
FAQ1-Stem Cell Therapy
http://youtu.be/dJHlHBrmvrU Stem cell therapy has earned global fame for its proven ability to help sufferers of many diseases, with little ill effects or si...
By: Kerry Dean
Read the rest here:
FAQ1-Stem Cell Therapy - Video
The Taste of Tomorrow: Genetic Engineering – The Daily Progress
By Dr. Matthew Watson
The Taste of Tomorrow: Genetic Engineering The Daily Progress Mr. Schonwald spent a considerable amount of time researching how genetic engineering might impact the salad bar of 2035. He explained, “When I started this project, I had a healthy suspicion of [genetically modified organisms]. I thought the idea of ... |
Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For … – Forbes
By Dr. Matthew Watson
Grist Challenges Its Own Shaky Crop Biotechnology Reporting, Sets Stage For ... Forbes That's been the reality for years at the otherwise respectable environmental news site Grist on the issue of agricultural biotechnology. This is why the current series by food writer Nathaniel Johnson reassessing Grist's own reporting on crop ... |
Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized – Forbes
By Dr. Matthew Watson
Commit To Purchase Puma Biotechnology At $45, Earn 14.8% Annualized Forbes Investors considering a purchase of Puma Biotechnology Puma Biotechnology, Inc. (NYSE: PBYI) shares, but cautious about paying the going market price of $53.61/share, might benefit from considering selling puts among the alternative strategies at their ... |
Biotechnology – Revolutions with Jon Faine – ABC Local
By Dr. Matthew Watson
ABC Local | Biotechnology - Revolutions with Jon Faine ABC Local This week Revolutions looks at the new possibilities opened up by biotechnology and talks to listeners about the procedures they've had, procedures that would have been thought impossible just a few decades ago. Joining Jon Faine for the discussion is ... |
The real impact for healthcare and biotechnology of the Supreme Court’s … – Lexology (registration)
By Dr. Matthew Watson
The real impact for healthcare and biotechnology of the Supreme Court's ... Lexology (registration) On June 13, 2013, the Supreme Court issued a decision supposedly resolving the patentability of DNA in Association for Molecular Pathology v. Myriad Genetics. Immediately, all parties on both sides of the case declared victory. The American Civil ... |
The top biotechnology companies in the Puget Sound area (slide show) – Puget Sound Business Journal (Seattle) (blog)
By Dr. Matthew Watson
The top biotechnology companies in the Puget Sound area (slide show) Puget Sound Business Journal (Seattle) (blog) The region's top biotechnology companies are extremely secretive about their revenues. That's one conclusion that can be drawn from the Puget Sound Business Journal's list of the top biotech firms in the area. Eleven of the top 25 companies would not ... |
Biotechnology: Monsanto drops new European GM food plans – Presseurop (English)
By Dr. Matthew Watson
Los Angeles Times | Biotechnology: Monsanto drops new European GM food plans Presseurop (English) United States biotech giant Monsanto is ending all but one project to grow GM foods in Europe, reports German daily Die Welt. The firm announced on July 17 that it is withdrawing all permits requested to the European Commission to grow genetically ... In Perspective: Anti-GM vitriol risesagprofessional.com Monsanto drops GM crop plan in EUBBC News Millions Against Monsanto: On the Road to VictoryTruth-Out The Southern Times -Malaysia Sun all 82 news articles » |
Applause for business achievements – Lima Ohio
By Dr. Matthew Watson
Applause for business achievements Lima Ohio He is a 1995 graduate of The Ohio State University with a bachelor's degree in science in molecular genetics. He then attended Kirksville College of Osteopathic Medicine in Kirksville, Mo., where he received his Doctorate of Osteopathic Medicine. In ... |
Treat an upset tummy with curd – Times of India
By Dr. Matthew Watson
Treat an upset tummy with curd Times of India Manuela Raffatellu, assistant professor of microbiology and molecular genetics, and colleagues at UC Irvine and the University of Washington identified how a probiotic strain of E. coli reduces salmonella colonization by competing with this pathogen ... |
CAMH scientists discover genetic changes that may contribute to the onset of … – Placentia Charter
By Dr. Matthew Watson
Placentia Charter | CAMH scientists discover genetic changes that may contribute to the onset of ... Placentia Charter The study is published in the current issue of Human Molecular Genetics, and was funded by the Canadian Institutes of Health Research (CIHR). In the first study of its kind, scientists at CAMH and The Centre for Applied Genomics (TCAG) at The Hospital ... |
“Molecular Postal System” Used in Quest to Develop Low-Cost Sterilization … – HealthCanal.com
By Dr. Matthew Watson
“Molecular Postal System” Used in Quest to Develop Low-Cost Sterilization ... HealthCanal.com WINSTON-SALEM, N.C. - As an expert in molecular genetics, Colin E. Bishop, Ph.D.'s, usual role at the Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is to apply the techniques of genetics and developmental biology to the ... |
Doctors apply lessons from boy’s case in sequencing genes of 25 other patients – Milwaukee Journal Sentinel
By Dr. Matthew Watson
Doctors apply lessons from boy's case in sequencing genes of 25 other patients Milwaukee Journal Sentinel Writing with two dozen colleagues, Howard Jacob, head of human and molecular genetics at the Medical College of Wisconsin, says the use of sequencing in hospitals "may still be debated, but we challenge the fence sitters to do 20 cases of their own and ... |
DNA enzyme’s speed confirms physics law – Futurity: Research News
By Dr. Matthew Watson
DNA enzyme's speed confirms physics law Futurity: Research News “Ever since the original experiments, we've noticed RecBCD molecules have quite a broad range of speeds,” says Kowalczykowski, a member of the department of microbiology and molecular genetics and the UC Davis Cancer Center. Liu used the ... |
LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The … – PR Web (press release)
By Dr. Matthew Watson
LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The ... PR Web (press release) Dr. Santani holds specialty board certifications in Clinical Molecular Genetics and Clinical Cytogenetics. Her primary focus is on new test development and adoption of next generation sequencing technologies for diagnostic testing. Dr. Santani has ... |
Paying for Human Eggs, Ivan Illich and Jerry Brown
By Dr. Matthew Watson
stalled in a technical parliamentary process as opponents continue to
wage their campaign urging Gov. Jerry Brown to veto the proposal,
which swept easily through the legislature.
industry-sponsored measure appeared this week as an op-ed in The Sacramento Bee. The legislation would allow women to be paid for eggs for scientific research. The op-ed piece invoked the philosopher Ivan Illich, a
longtime friend of Jerry Brown and much respected by him.
Scheper-Hughes of the Center for Genetics and Society of Berkeley,
the July 16 article said,
“The late historian of science and
technology, Ivan Illich, warned against the processes of medical
industries which 'create new needs and control their satisfaction and
turn human beings and their creativity into objects.'"
“Women's research eggs (have) become
the hot new bio-product, increasing the profits of the
multibillion-dollar-per-year infertility industry at the expense of
women's health, safety and possibly, their future fertility. Is this
the 'equity' we want for ourselves, our sisters and our daughters?”
Illich, whom he first met in 1976. Brown said that Illich
“...bore witness to the destructive
power of modern institutions that 'create needs faster than they can
create satisfaction, and in the process of trying to meet the needs
they generate, they consume the earth.'”
Assemblywoman Susan Bonilla, D-Concord) would remove a ban in
California on paying women who provide their eggs for scientific
research. Currently women who provide eggs for fertility purposes can
be paid, sometimes as much as $50,000, depending on the
characteristics of the woman providing the eggs. The bill would not
alter the ban on using research funds from the California stem cell
agency to pay for eggs. However, the agency next week will consider a proposal to allow use of agency funds to purchase stem cell lines
derived from eggs through compensation. (For
more information on
the bill,
see here, here and here.)
approval on July 1. The governor has 12 days to act on the measure
once it actually reaches his desk. However, as of this morning, the
legislation remained in what is known as the “engrossing and
enrolling” process. It could be a routine delay but the process can
also be used to manage the flow of legislation to the governor. Brown
is currently on a two-week trip to Germany and Ireland and is not
expected to return until near the first of August.
California Stem Cell Agency to Commit 20 Percent of Remaining Cash
By Dr. Matthew Watson
Thursday is expected to move forward with plans to give away $128
million, roughly 20 percent of its remaining funds.
of the $3 billion agency's hallmark efforts. The other “concept”
rounds up next week include a $35 million “tools and technology”RFA and $23 million to recruit four more star, stem cell scientists to California.
billion of its $3 billion so far with about $700 million available
for future spending. The remainder is going for the agency's
administrative expenses. Cash for new grants is expected to run out
sometime in 2017. Total cost of the agency's efforts run to about $6
billion because it operates with money borrowed by the state and must
pay interest.
developing a plan to develop new sources of funding with an eye on
some sort of public-private model. It solicited proposals in May for
help with the effort, with the goal of completing a plan by this
fall. At last report, however, the contract with the consultant had
not been let.
called, is likely to come up at next week's governing board meeting
along with a review of agency goals for the 2013-14 fiscal year.
also be heard by the agency's standards group next Wednesday.
implementing recommendations from a performance audit in May 2012.
The audit said the agency was laboring under a range of problems that
include protection of its intellectual property and management of its
nearly 500 grants plus an inadequate ability to track its own
performance. A staff Power Point presentation seems to indicate that it is making substantial progress in solving the problems identified by the audit.
Burlingame near the San Francisco Airport. Two remote locations where
the public can participate are also available in Los Angeles.
Addresses can be found on the agenda.
provide live coverage of the meeting based on the Internet audiocast
with stories filed as warranted.